Multi-marker strategies in heart failure: clinical and statistical approaches

Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89–95. doi: 10.1067/mcp.2001.113989

Vasan RS (2006) Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 113:2335–2362. doi: 10.1161/CIRCULATIONAHA.104.482570

Mark DB, Felker GM (2004) B-type natriuretic peptide—a biomarker for all seasons? N Engl J Med 350:718–720. doi: 10.1056/NEJMe038233

Morrow DA, de Lemos JA (2007) Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation 115:949–952. doi: 10.1161/CIRCULATIONAHA.106.683110

Donahue MP, Marchuk DA, Rockman HA (2006) Redefining heart failure: the utility of genomics. J Am Coll Cardiol 48:1289–1298. doi: 10.1016/j.jacc.2006.05.062

Arab S, Gramolini AO, Ping P et al (2006) Cardiovascular proteomics: tools to develop novel biomarkers and potential applications. J Am Coll Cardiol 48:1733–1741. doi: 10.1016/j.jacc.2006.06.063

Braunwald E (2008) Biomarkers in heart failure. N Engl J Med 358:2148–2159. doi: 10.1056/NEJMra0800239

Morrow DA, de Lemos JA, Sabatine MS, Antman EM (2003) The search for a biomarker of cardiac ischemia. Clin Chem 49:537–539. doi: 10.1373/49.4.537

Morrow DA, Braunwald E (2003) Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy. Circulation 108:250–252. doi: 10.1161/01.CIR.0000078080.37974.D2

Newby LK, Storrow AB, Gibler WB et al (2001) Bedside multimarker testing for risk stratification in chest pain units: The chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study. Circulation 103:1832–1837

James SK, Lindback J, Tilly J et al (2006) Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy. J Am Coll Cardiol 48:1146–1154. doi: 10.1016/j.jacc.2006.05.056

Sabatine MS, Morrow DA, de Lemos JA et al (2002) Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105:1760–1763. doi: 10.1161/01.CIR.0000015464.18023.0A

Westerhout CM, Fu Y, Lauer MS et al (2006) Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers. J Am Coll Cardiol 48:939–947. doi: 10.1016/j.jacc.2006.04.085

Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97:1837–1847

Ridker PM, Rifai N, Rose L, Buring JE, Cook N (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347:1557–1565. doi: 10.1056/NEJMoa021993

Ralli S, Horwich TB, Fonarow GC (2005) Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failure. Am Heart J 150:1220–1227. doi: 10.1016/j.ahj.2005.01.049

van Kimmenade RR, Januzzi JL Jr, Baggish AL et al (2006) Amino-terminal pro-brain natriuretic peptide, renal function, and outcomes in acute heart failure: redefining the cardiorenal interaction? J Am Coll Cardiol 48:1621–1627. doi: 10.1016/j.jacc.2006.06.056

Januzzi JL Jr, Peacock WF, Maisel AS et al (2007) Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study. J Am Coll Cardiol 50:607–613. doi: 10.1016/j.jacc.2007.05.014

Rehman SU, Martinez-Rumayor A, Mueller T, Januzzi JL Jr (2008) Independent and incremental prognostic value of multimarker testing in acute dyspnea: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Clin Chim Acta 392:41–45. doi: 10.1016/j.cca.2008.03.002

van Kimmenade RR, Januzzi JL Jr, Ellinor PT et al (2006) Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol 48:1217–1224. doi: 10.1016/j.jacc.2006.03.061

Anand IS, Rector T, Latini R, Masson S, Maggioni AP, Cohn JN (2006) Do biomarkers add prognostic information to routine measures of the severity of heart failure? J Am Coll Cardiol 47(4A):A66–A67. doi: 10.1016/j.jacc.2005.12.054

Latini R, Masson S, Anand IS et al (2007) Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 116:1242–1249. doi: 10.1161/CIRCULATIONAHA.106.655076

Diamond GA, Denton TA, Berman DS, Cohen I (1995) Prior restraint: a Bayesian perspective on the optimization of technology utilization for diagnosis of coronary artery disease. The American Journal of Cardiology 76:82–86. doi: 10.1016/S0002-9149(99)80809-1

Maisel AS, Krishnaswamy P, Nowak RM et al (2002) Rapid measurement of b-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347:161–167. doi: 10.1056/NEJMoa020233

Kattan MW (2003) Judging new markers by their ability to improve predictive accuracy. J Natl Cancer Inst 95:634–635

Cook NR (2007) Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115:928–935. doi: 10.1161/CIRCULATIONAHA.106.672402

Baggish AL, Siebert U, Lainchbury JG et al (2006) A validated clinical and biochemical score for the diagnosis of acute heart failure: the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Acute Heart Failure Score. Am Heart J 151:48–54. doi: 10.1016/j.ahj.2005.02.031

Zheng Y, Cai T, Feng Z (2006) Application of the time-dependent roc curves for prognostic accuracy with multiple biomarkers. Biometrics 62:279–287. doi: 10.1111/j.1541-0420.2005.00441.x

Heagerty PJ, Zheng Y (2005) Survival model predictive accuracy and ROC curves. Biometrics 61:92–105. doi: 10.1111/j.0006-341X.2005.030814.x

Morrow DA, Antman EM, Charlesworth A et al (2000) TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 102:2031–2037

Levy WC, Mozaffarian D, Linker DT et al (2006) The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 113:1424–1433. doi: 10.1161/CIRCULATIONAHA.105.584102

Felker GM, Leimberger JD, Califf RM et al (2004) Risk stratification after hospitalization for decompensated heart failure. Journal of Cardiac Failure 10:460–466. doi: 10.1016/j.cardfail.2004.02.011

Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ for the Adhere Scientific Advisory Committee Study Group and Investigators (2005) Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. J Am Med Assoc 293:572–580. doi: 10.1001/jama.293.5.572

Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM (1997) Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 95:2660–2667

Atienza F, Martinez-Alzamora N, De Velasco JA, Dreiseitl S, Ohno-Machado L (2000) Risk stratification in heart failure using artificial neural networks. Proc AMIA Symp 3:2–6

Ortiz J, Ghefter CG, Silva CE, Sabbatini RM (1995) One-year mortality prognosis in heart failure: a neural network approach based on echocardiographic data. J Am Coll Cardiol 26:1586–1593. doi: 10.1016/0735-1097(95)00385-1

Penny W, Frost D (1996) Neural networks in clinical medicine. Med Decis Making 16:386–398. doi: 10.1177/0272989X9601600409

Goodman E, Dolan LM, Morrison JA, Daniels SR (2005) Factor analysis of clustered cardiovascular risks in adolescence: obesity is the predominant correlate of risk among youth. Circulation 111:1970–1977. doi: 10.1161/01.CIR.0000161957.34198.2B